Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
7,799,450
-
Shares change
-
+3,882,512
-
Total reported value, excl. options
-
$88,919,578
-
Value change
-
+$45,837,712
-
Put/Call ratio
-
19%
-
Number of buys
-
56
-
Number of sells
-
-15
-
Price
-
$11.40
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q2 2018
87 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q2 2018.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,799,450 shares
of 65,881,982 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,706,847 shares), VANGUARD GROUP INC (1,255,761 shares), Skylands Capital, LLC (496,550 shares), STATE STREET CORP (434,632 shares), NORTHERN TRUST CORP (309,268 shares), Manatuck Hill Partners, LLC (258,200 shares), Allianz Asset Management GmbH (257,670 shares), GEODE CAPITAL MANAGEMENT, LLC (239,199 shares), RENAISSANCE TECHNOLOGIES LLC (230,300 shares), and TWO SIGMA ADVISERS, LP (214,151 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.